Anti-SLAMF7 CAR T Cells


The National Cancer Institute (NCI) has constructed a novel anti-SLAMF7 CAR T cell therapy that can specifically recognize SLAMF7- expressing target cells and eradicate SLAMF7-expressing tumors in mice.

SparkCures ID 342
Generic Name Anti-SLAMF7 CAR T Cells
Treatment Classifications
Treatment Targets

Clinical Trials


There are no resources, links or videos to display for this treatment.